ImmunoMind Companies
The company's platform focuses on the identification of complex cell populations with desired properties in drug development and manufacturing of cell therapies, enabling medical researchers to help design and produce safe and effective CAR-T therapies.ImmunoMind. Company Profile: Valuation & Investors | PitchBookpitchbook.com/profiles/company/438595-48
Technology:
Companies
Industry:
AI R&D Pharma (DPI)
Headquarters:
Berkeley, Alameda County, California, United States
Founded Date:
2020
Register and Claim Ownership